These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 23782447)

  • 1. A phase II randomized clinical trial on cerebral near-infrared spectroscopy plus a treatment guideline versus treatment as usual for extremely preterm infants during the first three days of life (SafeBoosC): study protocol for a randomized controlled trial.
    Hyttel-Sorensen S; Austin T; van Bel F; Benders M; Claris O; Dempsey E; Fumagalli M; Greisen G; Grevstad B; Hagmann C; Hellström-Westas L; Lemmers P; Lindschou J; Naulaers G; van Oeveren W; Pellicer A; Pichler G; Roll C; Skoog M; Winkel P; Wolf M; Gluud C
    Trials; 2013 May; 14():120. PubMed ID: 23782447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral near infrared spectroscopy oximetry in extremely preterm infants: phase II randomised clinical trial.
    Hyttel-Sorensen S; Pellicer A; Alderliesten T; Austin T; van Bel F; Benders M; Claris O; Dempsey E; Franz AR; Fumagalli M; Gluud C; Grevstad B; Hagmann C; Lemmers P; van Oeveren W; Pichler G; Plomgaard AM; Riera J; Sanchez L; Winkel P; Wolf M; Greisen G
    BMJ; 2015 Jan; 350():g7635. PubMed ID: 25569128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral near-infrared spectroscopy monitoring versus treatment as usual for extremely preterm infants: a protocol for the SafeBoosC randomised clinical phase III trial.
    Hansen ML; Pellicer A; Gluud C; Dempsey E; Mintzer J; Hyttel-Sørensen S; Heuchan AM; Hagmann C; Ergenekon E; Dimitriou G; Pichler G; Naulaers G; Cheng G; Guimarães H; Tkaczyk J; Kreutzer KB; Fumagalli M; Claris O; Lemmers P; Fredly S; Szczapa T; Austin T; Jakobsen JC; Greisen G
    Trials; 2019 Dec; 20(1):811. PubMed ID: 31888764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical use of cerebral oximetry in extremely preterm infants is feasible.
    Hyttel-Sørensen S; Austin T; van Bel F; Benders M; Claris O; Dempsey EM; Fumagalli M; Gluud C; Hagmann C; Hellström-Westas L; Lemmers P; Naulaers G; van Oeveren W; Pellicer A; Pichler G; Roll C; Støy LS; Wolf M; Greisen G
    Dan Med J; 2013 Jan; 60(1):A4533. PubMed ID: 23340184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral Oxygen Saturation to Guide Oxygen Delivery in Preterm Neonates for the Immediate Transition after Birth: A 2-Center Randomized Controlled Pilot Feasibility Trial.
    Pichler G; Urlesberger B; Baik N; Schwaberger B; Binder-Heschl C; Avian A; Pansy J; Cheung PY; Schmölzer GM
    J Pediatr; 2016 Mar; 170():73-8.e1-4. PubMed ID: 26743498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detailed statistical analysis plan for the SafeBoosC III trial: a multinational randomised clinical trial assessing treatment guided by cerebral oxygenation monitoring versus treatment as usual in extremely preterm infants.
    Hansen ML; Pellicer A; Gluud C; Dempsey E; Mintzer J; Hyttel-Sorensen S; Heuchan AM; Hagmann C; Dimitriou G; Pichler G; Naulaers G; Cheng G; Vilan A; Tkaczyk J; Kreutzer KB; Fumagalli M; Claris O; Fredly S; Szczapa T; Lange T; Jakobsen JC; Greisen G
    Trials; 2019 Dec; 20(1):746. PubMed ID: 31856902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early biomarkers of brain injury and cerebral hypo- and hyperoxia in the SafeBoosC II trial.
    Plomgaard AM; Alderliesten T; Austin T; van Bel F; Benders M; Claris O; Dempsey E; Fumagalli M; Gluud C; Hagmann C; Hyttel-Sorensen S; Lemmers P; van Oeveren W; Pellicer A; Petersen TH; Pichler G; Winkel P; Greisen G
    PLoS One; 2017; 12(3):e0173440. PubMed ID: 28328980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral regional tissue Oxygen Saturation to Guide Oxygen Delivery in preterm neonates during immediate transition after birth (COSGOD III): an investigator-initiated, randomized, multi-center, multi-national, clinical trial on additional cerebral tissue oxygen saturation monitoring combined with defined treatment guidelines versus standard monitoring and treatment as usual in premature infants during immediate transition: study protocol for a randomized controlled trial.
    Pichler G; Baumgartner S; Biermayr M; Dempsey E; Fuchs H; Goos TG; Lista G; Lorenz L; Karpinski L; Mitra S; Kornhauser-Cerar L; Avian A; Urlesberger B; Schmölzer GM
    Trials; 2019 Mar; 20(1):178. PubMed ID: 30894226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The SafeBoosC phase II randomised clinical trial: a treatment guideline for targeted near-infrared-derived cerebral tissue oxygenation versus standard treatment in extremely preterm infants.
    Pellicer A; Greisen G; Benders M; Claris O; Dempsey E; Fumagalli M; Gluud C; Hagmann C; Hellström-Westas L; Hyttel-Sorensen S; Lemmers P; Naulaers G; Pichler G; Roll C; van Bel F; van Oeveren W; Skoog M; Wolf M; Austin T
    Neonatology; 2013; 104(3):171-8. PubMed ID: 23921600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral oximetry monitoring versus usual care for extremely preterm infants: a study protocol for the 2-year follow-up of the SafeBoosC-III randomised clinical trial.
    Rasmussen MI; Hansen ML; Pellicer A; Gluud C; Dempsey E; Mintzer J; Hyttel-Sørensen S; Heuchan AM; Hagmann C; Ergenekon E; Dimitriou G; Pichler G; Naulaers G; Cheng G; Tkaczyk J; Fuchs H; Fumagalli M; Nesargi S; Fredly S; Szczapa T; Plomgaard AM; Hansen BM; Jakobsen JC; Greisen G
    Trials; 2023 Oct; 24(1):653. PubMed ID: 37805539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral near-infrared spectroscopy monitoring for prevention of brain injury in very preterm infants.
    Hyttel-Sorensen S; Greisen G; Als-Nielsen B; Gluud C
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD011506. PubMed ID: 28869278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of cerebral oximetry in mechanically ventilated newborns: a protocol for the SafeBoosC-IIIv randomised clinical trial.
    Vestager ML; Hansen ML; Rasmussen MI; Hahn GH; Hyttel-Sørensen S; Pellicer A; Heuchan AM; Hagmann C; Dempsey E; Dimitriou G; Pichler G; Naulaers G; Fuchs H; Tkaczyk J; Mintzer J; Fumagalli M; Nesargi S; Fredly S; Szczapa T; Gluud C; Jakobsen JC; Greisen G
    Trials; 2023 Oct; 24(1):696. PubMed ID: 37898759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The SafeBoosC phase II clinical trial: an analysis of the interventions related with the oximeter readings.
    Riera J; Hyttel-Sorensen S; Bravo MC; Cabañas F; López-Ortego P; Sanchez L; Ybarra M; Dempsey E; Greisen G; Austin T; Claris O; Fumagalli M; Gluud C; Lemmers P; Pichler G; Plomgaard AM; van Bel F; Wolf M; Pellicer A
    Arch Dis Child Fetal Neonatal Ed; 2016 Jul; 101(4):F333-8. PubMed ID: 26645538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detailed statistical analysis plan for a secondary Bayesian analysis of the SafeBoosC-III trial: a multinational, randomised clinical trial assessing treatment guided by cerebral oximetry monitoring versus usual care in extremely preterm infants.
    Olsen MH; Hansen ML; Lange T; Gluud C; Thabane L; Greisen G; Jakobsen JC;
    Trials; 2023 Nov; 24(1):737. PubMed ID: 37974280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No neurodevelopmental benefit of cerebral oximetry in the first randomised trial (SafeBoosC II) in preterm infants during the first days of life.
    Plomgaard AM; Alderliesten T; van Bel F; Benders M; Claris O; Cordeiro M; Dempsey E; Fumagalli M; Gluud C; Hyttel-Sorensen S; Lemmers P; Pellicer A; Pichler G; Greisen G
    Acta Paediatr; 2019 Feb; 108(2):275-281. PubMed ID: 29908039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral Oxygenation and Autoregulation in Preterm Infants (Early NIRS Study).
    Chock VY; Kwon SH; Ambalavanan N; Batton B; Nelin LD; Chalak LF; Tian L; Van Meurs KP
    J Pediatr; 2020 Dec; 227():94-100.e1. PubMed ID: 32818482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral oxygenation during skin-to-skin care in preterm infants not receiving respiratory support.
    Lorenz L; Marulli A; Dawson JA; Owen LS; Manley BJ; Donath SM; Davis PG; Kamlin COF
    Arch Dis Child Fetal Neonatal Ed; 2018 Mar; 103(2):F137-F142. PubMed ID: 28747364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early cerebral hypoxia in extremely preterm infants and neurodevelopmental impairment at 2 year of age: A post hoc analysis of the SafeBoosC II trial.
    Plomgaard AM; Schwarz CE; Claris O; Dempsey EM; Fumagalli M; Hyttel-Sorensen S; Lemmers P; Pellicer A; Pichler G; Greisen G
    PLoS One; 2022; 17(1):e0262640. PubMed ID: 35073354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase-II clinical trial of targeted cerebral near infrared spectroscopy using standardized treatment guidelines to improve brain oxygenation in preterm infants (BOx-II): A study protocol.
    Vesoulis Z; Hopper A; Fairchild K; Zanelli S; Chalak L; Noroozi M; Liu J; Chock V
    Contemp Clin Trials; 2022 Sep; 120():106886. PubMed ID: 35995129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resuscitation of very preterm infants with 30% vs. 65% oxygen at birth: study protocol for a randomized controlled trial.
    Rook D; Schierbeek H; van der Eijk AC; Longini M; Buonocore G; Vento M; van Goudoever JB; Vermeulen MJ
    Trials; 2012 May; 13():65. PubMed ID: 22621326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.